🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An observational, prospective, mixed-methods study involving the integratio...
Status
Completed
Location
Centre Hospitalier Universitair de Lille
Start Date
2021-11-24
Trial ID
NCT05181839
Treatments Being Tested
A Phase 1/2, Open-label, Multicenter, Non-randomized Study to Assess the Sa...
Status
Completed
Location
Kepler Universitaetsklinikum GmbH
Start Date
2020-02-26
Trial ID
NCT04188964
Treatments Being Tested
X-linked hypophosphataemia (XLH) is a rare genetic disorder associated with...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06248632
Treatments Being Tested
The primary objective of this study is to evaluate the effect of KRN23 (bur...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2016-09-08
Trial ID
NCT02915705
Treatments Being Tested
The purpose of this study is to better understand how X-linked hypophosphat...
Status
Withdrawn
Location
Yale University School of Medicine
Start Date
2026-07-07
Trial ID
NCT07607600
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Yale University School of Medicine
Start Date
2008-12
Trial ID
NCT00830674
Before switching to the post-marketing study: Assess the efficacy and safe...
Status
Completed
Location
Hokkaido University Hospital
Start Date
2018-01-09
Trial ID
NCT04308096
Treatments Being Tested
The objectives of this observational study are to assess the long-term safe...
Status
Active Not Recruiting
Location
Yale University
Start Date
2022-01-31
Trial ID
NCT04783428
Treatments Being Tested
The purpose of this study is to assess the safety, pharmacokinetics and eff...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-09-28
Trial ID
NCT04842019
Treatments Being Tested
X-linked hypophosphataemia (XLH) is a rare, hereditary condition. The genet...
Status
Recruiting
Location
Nottingham University Hospitals NHS Trust
Start Date
2025-11-03
Trial ID
NCT07183579